SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

Share Price is delayed by 15 minutes
Get Live Data
154.40    1.60 (1.05%)
Bid:
154.40
Ask:
154.80
Spread: 0.40 (0.259%)
Market Cap: £883.65m
ELM Live PriceLast checked at - London Stock Exchange

Intraday Elementis Share Chart

Trading Statement

27 Oct 2017 07:00

ELEMENTIS PLC - Trading Statement

ELEMENTIS PLC - Trading Statement

PR Newswire

London, October 26

Elementis plc

Q3 Trading Update

Sustained good revenue performance and overall trading on track

Elementis plc (“Elementis” or the “Group”), a Global Specialty Chemicals Company, today issues its planned period end trading update for the three months ended 30 September 2017.

In the third quarter the Group has performed in line with expectations and seen a continuation of the trends experienced across the first half of the year.

Specialty Products performed well and in line with expectations

Coatings saw a good sales performance across all regions versus last year, however higher raw material costs impacted profit growth.

Personal Care continued to benefit from increased penetration of our hectorite based products across categories and geographies. The integration of SummitReheis remains on track with synergies well underpinned, and we continue to implement pricing responses to recover raw material cost inflation. We are creating a Personal Care business of scale.

Energy has remained strong, reflecting higher activity levels and market share gains. Momentum in the business remains extremely positive.

Chromium on track to deliver full year improvement

Chromium has continued to perform well and in line with the trends experienced across the first half of the year. Despite unplanned production outages at our Castle Hayne and Corpus Christi facilities during the third quarter we continue to expect an improved full year outcome versus 2016.

Surfactants disposal progressing well

As previously indicated, the favourable first half conditions in Surfactants have not continued. The sale process for the business is progressing well and we continue to expect resolution in early 2018.

Commenting on the performance, CEO, Paul Waterman said,

“Elementis has delivered another good revenue performance in the third quarter and overall trading is on track. Trends remain similar to those reported in the first half of the year and we remain on course to grow operating profit across all three segments in 2017. Going forward, we continue to see significant potential for Elementis as we implement our Reignite Growth strategy”.

Enquiries

Elementis plc

James Curran, Investor Relations Tel: 020 7067 2994

Martin Robinson, Tulchan Tel: 020 7353 4200

Date   Source Headline
12th Nov 20209:39 amRNSResponse to Minerals Technologies Inc announcement
12th Nov 20207:51 amRNSStatement re Possible Offer
9th Nov 20204:55 pmRNSHolding(s) in Company
28th Oct 20207:00 amRNSQ3 Trading Update
26th Oct 20207:00 amRNSUpdate on 2020 AGM resolution vote
16th Oct 20207:00 amRNSDirectorate Change
17th Sep 202012:40 pmRNSDirector/PDMR Shareholding
7th Sep 20207:00 amRNSCovenant update
1st Sep 20202:22 pmRNSBlock listing Interim Review
28th Jul 20207:00 amRNSHalf-year Report
8th Jun 20204:28 pmRNSHolding(s) in Company
15th May 20201:08 pmRNSHolding(s) in Company
1st May 20209:56 amRNSTotal Voting Rights
29th Apr 202011:02 amRNSDirector Declaration
29th Apr 202010:49 amRNSResult of AGM
29th Apr 20207:00 amRNSAGM Trading Statement
28th Apr 202012:06 pmRNSDisclosure of rights attached to equity shares
21st Apr 20207:00 amRNSAGM update
8th Apr 202011:50 amRNSDirector/PDMR Shareholding
2nd Apr 20202:51 pmRNSHolding(s) in Company
1st Apr 20208:13 amRNSDirector Declaration
25th Mar 20204:04 pmRNSAnnual Financial Report
25th Mar 202010:19 amRNSHolding(s) in Company
24th Mar 20209:02 amRNSHolding(s) in Company
23rd Mar 20205:25 pmRNSHolding(s) in Company
20th Mar 20205:28 pmPRNDirector/PDMR Shareholding
20th Mar 20205:07 pmRNSDirector/PDMR Shareholding
20th Mar 20205:06 pmRNSDirector/PDMR Shareholding
20th Mar 202010:44 amRNSHolding(s) in Company
19th Mar 20204:28 pmRNSDirector/PDMR Shareholding
19th Mar 20204:25 pmRNSDirector/PDMR Shareholding
19th Mar 20204:24 pmRNSDirector/PDMR Shareholding
19th Mar 20207:00 amPRNCOVID-19 update
18th Mar 20203:14 pmRNSAdditional Listing
17th Mar 202010:25 amRNSDirector/PDMR Shareholding
12th Mar 202010:36 amRNSDirector/PDMR Shareholding
10th Mar 20202:02 pmRNSDirector/PDMR Shareholding
9th Mar 202010:57 amRNSDirector/PDMR Shareholding
6th Mar 20202:36 pmRNSDirector/PDMR Shareholding
6th Mar 20202:35 pmRNSDirector/PDMR Shareholding
5th Mar 20201:41 pmRNSDirector/PDMR Shareholding
4th Mar 20207:00 amRNS2019 Preliminary Results Announcement
2nd Mar 20203:46 pmRNSBlock listing Interim Review
2nd Mar 202011:22 amPRNTotal Voting Rights
4th Feb 20207:00 amRNSDirectorate Change
21st Jan 20208:46 amPRNDirector Declaration
20th Jan 202010:54 amPRNHolding(s) in Company
14th Jan 20207:00 amRNSTrading update
6th Jan 202010:09 amPRNHolding(s) in Company
2nd Jan 202011:12 amPRNTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.